All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0853 | Anti-GLTP (CBFYH-0394) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0394 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4106 | Anti-GLTP (CBFYH-0394) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-0394 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1215 | Anti-GLTP (2A10) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2A10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1216 | Anti-GLTP (CBLG1-3185) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3185 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1217 | Anti-GLTP (CBLG1-3186) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3186 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1218 | Anti-GLTP (CBLG1-2824) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2824 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2855 | Anti-GLTP(2A10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2A10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2856 | Anti-GLTP(CBLG1-3185) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3185 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2857 | Anti-GLTP(CBLG1-3186) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3186 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2858 | Anti-GLTP(CBLG1-2824) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2824 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION